Adherence in Pediatric Multiple Sclerosis
Treatment Adherence in Pediatric Multiple Sclerosis
Sponsor: Alberta Children's Hospital
A NA clinical study on Multiple Sclerosis, this trial is completed. The trial is conducted by Alberta Children's Hospital and has accumulated 10 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
-
Sep 2020 — Jan 2021 [monthly]
Completed NA
-
Feb 2020 — Sep 2020 [monthly]
Completed NA
-
Jun 2018 — Feb 2020 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Alberta Children's Hospital
- Baylor College of Medicine
- Boston Children's Hospital
- Children's Hospital of Philadelphia
- DeltaQuest Foundation
- Loma Linda University
- Mayo Clinic
- National Multiple Sclerosis Society
- The Cleveland Clinic
- The Hospital for Sick Children
- University of Alabama at Birmingham
- University of California, San Francisco
- University of Colorado, Denver
- University of Pittsburgh
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .